Abstract
Introduction w x q
In 1983, Noma 1 inferred that the ATP-dependent K Ž . channels K channels open by a fall in the cytosolic ATP ATP concentration and play a cardioprotective role during myocardial ischemia or hypoxia in non-diabetic hearts w x 2-5 . Thus, blocking the K channels may be detrimen-ATP tal to the ischemic myocardium. In 1970, patients with Ž . diabetes mellitus DM treated with the oral hypoglycemic drug, tolbutamide, were reported to have a higher mortality w x than those without treatment 6 . Tolbutamide, a sulphonylurea derivative, blocks the K channels in the beta-cells ATP w x w x of the pancreas 7 and the myocardial cells 1, 8 . The detrimental effects may be partly caused by the dysfuncw x tion of the K channel in the myocardium 9 .
ATP
Diabetics have an increased incidence of congestive heart failure despite smaller infarct areas following isw x chemia than non-diabetics 10 ; during exercise the same is true even in young men with no evidence of cardiovascular w x disease 11 . In our previous studies in isolated perfused rat w x hearts 12-15 , we showed the diabetic heart to be more susceptible than the non-diabetic heart to flow reduction and to exhibit contractile dysfunctions and abnormal en-Ž . ergy metabolism of the left ventricular LV wall readily;
Ž . norepinephrine NE exacerbated this effect, particularly in w x the diabetic heart 12,13,15 . Diabetic hearts were more susceptible to a decrease of total ATP in the tissue during underperfusion with NE; the increase in LV stiffness correlated closely with ATP depletion in the subendocardium w x w x w x 13 , and in vivo 12 and ex vivo 14 insulin prevented the injury.
Therefore, it is important to clarify the participation of the K channels in cardiac dysfunction during underper-ATP fusion in the diabetic heart, particularly the heart treated with sulphonylurea derivatives. In the present study, we Ž examined the effects of glyburide glibenclamide, a sulphonylurea anti-diabetic drug and a specific K chan-
. w x nel inhibitor 16 on the dysfunction during underperfusion with NE in isolated 6-week streptozotocin-induced diabetic rat hearts. We focused on the increase in LV diastolic stiffness, changes in regional myocardial flow distribution and regional abnormal myocardial energy metabolism. We also investigated whether levcromakalim Ž q . a selective K channel and a K channel opener ATP w x 17-19 prevents the effects of glyburide. The beneficial metabolic effects of sulphonylurea derivatives in non-insulin-dependent DM are considered to be based on an augmented release of insulin from the beta-cells of the w x pancreas 20 . Therefore, we examined the effects of glyburide in the absence and presence of ex vivo insulin.
Methods

Animals and treatment
Ž
. Diabetes mellitus DM was induced by a single intra-Ž . Ž . venous i.v. injection of 50 mgrkg streptozotocin Sigma in 8-week-old male Sprague-Dawley rats, each weighing Ž . 250 " 3 g ns42 . The diabetic state was assessed by confirming that blood glucose in the evening was ) 300 Ž . mgrdl with the Glucoboy set E-PG30, Eikenkagaku 3 days after the injection of streptozotocin. The rats were housed in groups of 2-4 to a cage and received food and water ad libitum and were killed 44 " 0 days after the injection. The investigation conforms with the principles outlined in the Declaration of Helsinki.
2.2.
Heart perfusion and measurement of mechanical performance w x As described previously 12-15 , the animals were anesthetized with ether and venous blood samples were obtained for measurement of plasma glucose by an enzy-Ž . matic method with Glu neo Shinotest .
After thoracotomy, the hearts were rapidly excised and perfused with a Langendorff apparatus. with 95% O r5% CO . Mean coronary perfusion pressure 2 2 Ž . CPP was measured through a side tube of the cannula Ž . inserted in the aorta. Heart rate HR was measured with a Ž . cardiotachometer AT-601G, Nihon Kohden . Coronary Ž . flow rate CFR was measured by collecting drops of venous effluent from the heart and was gradually increased Ž . by a microtube pump Minipuls 2, Gilson to provide a CPP of about 55 mmHg. The hearts were then paced at Ž 300 beatsrmin by an electronic stimulator SEN-3301, . Nihon Kohden throughout the experiments.
To detect changes in the contractile responses of the left ventricle, the isometric tension along the longitudinal diw Ž .x rection of the whole heart as contractile force CF and w Ž .x the isovolumic pressure as left ventricular pressure LVP were monitored simultaneously. To monitor CF, a force-Ž displacement transducer TB-611T and AP-621G, Nihon . Kohden was attached by a thread with a hook to the ventricular apex. To monitor LVP, a fluid-filled balloon Ž connected to a pressure transducer TP-101T and AP-620G, . Nihon Kohden was placed in the left ventricle. Diastolic Ž . force resting tension in the CF and the LV diastolic pressure were expressed in terms of resting CF and resting LVP, respectively. The resting CF and resting LVP during the normal perfusion before the infusion of agents were almost adjusted to 1 g and 0 mmHg, respectively, and Ž . differences D g and D mmHg from the normal perfusion levels just before underperfusion were measured to detect changes in LV stiffness. CF and LVP developed from the diastolic to the systolic tension and pressure were measured as developed CF and developed LVP, respectively; the "dFrdt and the "dPrdt were derived with differen-Ž . tiators ED-601G, Nihon Kohden , respectively. Fig. 1 shows the perfusion protocol. The paced diabetic hearts were divided into two groups-normal perfusion Ž . and underperfusion with norepinephrine NE . In the nor-Ž . mal perfusion group n s 7 , the hearts were perfused at a flow rate adjusted to provide a CPP of about 55 mmHg Ž . normal perfusion for 90 min. In the underperfusion with Ž NE group, after 30-min normal perfusion CFR was 6.30 . " 0.11 mlrminrg heart weight, n s 42 , the hearts were exposed to 60-min underperfusion by reducing the flow rate to 2 mlrminrg heart weight, and 5 min after the start of underperfusion the perfusate was changed to that cony6 Ž . taining 10 M NE Sankyo . The 60-min underperfusion with NE group was divided into 4 subgroups: 0.002% Ž . dimethyl sulfoxide DMSO as a solvent, Sigma subgroup Ž n s 6 for measuring tissue substrates and n s 5 for mea-. suring regional flow rate ; 10 M glyburide subgroup Ž n s 7 for measuring tissue substrates and n s 6 for mea-.
Perfusion protocol
y4
suring regional flow rate ; glyburide q 10 M levcro-Ž . Ž makalim subgroup n s 5 ; and glyburide q insulin 2 . Ž mUrminrg heart weight, Novo, Actrapid subgroup n s . 6 . Insulin was infused 25 min before, and DMSO, glyburide and levcromakalim were infused 15 min before and Ž . during underperfusion by an infusion pump SP-60, Nipro . Glyburide and levcromakalim were dissolved in DMSO. The solutions containing the agents were diluted with Krebs-Henseleit solution and infused at a rate of 0.1 mlrmin into the perfusate. The above concentrations of the agents are those during underperfusion. At the end of each perfusion the hearts were quickly frozen in liquid nitrogen for subsequent measurement of tissue substrates.
Determination of myocardial energy metabolites
The tissue substrate concentration in the subendocardium and the subepicardium of the left ventricle was measured and analyzed separately. The LV free walls of the frozen hearts were dissected into inner and outer halves, which corresponded to the subendocardial and subepicardial portions, respectively. The solidly frozen Ž . tissue was weighed wet weight .
After a 5-h lyophilization, the dried tissue was again Ž . weighed dry weight . The tissue water content was estimated from the wet and dry weights. The dried tissue was extracted with 0.6 M perchloric acid. The mixture was centrifuged at 12 000 = g for 15 min at 28C, and the supernatant was used to determine tissue metabolites. . w x Mannheim , as described in our previous paper 15 in detail. Fig. 1 . Perfusion protocol. All isolated diabetic rat hearts were paced at 300 beatsrmin and perfused with Krebs-Henseleit solution containing 11 mM Ž . Ž . glucose at 368C throughout the experiments. Flow rate was adjusted to provide a coronary perfusion pressure CPP of about 55 mmHg normal perfusion , Ž . using a microtube pump. In the control normal perfusion group, the hearts were perfused at the flow rate for 90 min. In the underperfusion with Ž . norepinephrine NE group, after 30-min normal perfusion, the hearts were exposed to 60-min underperfusion by reducing the flow rate to 2 mlrminrg heart weight and 5 min after the start of underperfusion, the perfusate was changed to that containing 10 y6 M NE. In agent-treated subgroups, insulin and Ž . other agents glyburide andror levcromakalim were infused 25 and 15 min before, respectively, and during underperfusion, at a rate of 0.1 mlrmin into Ž . the perfusate by an infusion pump. At the end of the perfusion the hearts were quickly frozen in liquid nitrogen arrows to measure tissue substrates. 
Measurement of regional myocardial flow rate
Tissue flow distribution was determined by the dye Ž . microspheres method with Dye-trak Primetech in the DMSO and the glyburide subgroups. Blue and yellow Ž microspheres diameter, 15 mm; density, about 50 000r50 . ml of 0.01% Tween 80 were injected into the coronary perfusion line just before and after 60-min underperfusion, respectively. The effluences were collected for 5 min after each injection. The hearts were dissected into 6 portions-both atria, the right ventricular free wall, the ventricular septum, the subendocardium, and the subepicardium of the LV free wall, and the apex. The 6 portions were lyophilized and the dried tissues were weighed. Each dried tissue was dissolved in 4 M KOHr20% Tween 80 Ž . Sigma . Multiple dye microspheres in the solutions were collected using a 10-mm pored filter, and the dyes were Ž . dissolved in N, N-dimethylformamide Nacalai and deter-Ž mined with a UV-VIS recording spectrophotometer UV-. 2200A, Shimadzu .
Statistics
In Figs. 2-6 and Table 1 , the analysis of variance Ž . w x ANOVA for multiple comparisons 23 was restricted to the underperfusion with NE subgroups. The data for the differences among the subgroups were first assessed statistically by two-way ANOVA, and then at any perfusion period by one-way ANOVA and the Scheffe method aś post-hoc test. In Table 1 , all the flow data for the differ-Ž ences between the levels just before at the normal perfu-. sion and 60 min after the start of underperfusion with NE, and between the LV subendocardium and subepicardium were also assessed statistically by the Student t-test. We focused on the differences between the LV subendo-
Ž . Ž . Ž . Fig. 4 . The developed contractile force CF and the peak diastolic y and systolic q dFrdt in the normal perfusion group open circles , and during Ž . Ž . Ž . underperfusion with NE in the DMSO solid circles , the glyburide solid triangles and the glyburideqlevcromakalim subgroups open triangles . CF developed from the diastolic to the systolic tension along the longitudinal direction of the whole heart was measured as developed CF. Vertical lines indicate s.e. ) P -0.05, ) ) P -0.01 vs. DMSO subgroup;
q P - cardium and subepicardium to clarify the relationship between the regional flow and myocardial energy metabolism. In Table 2 , all the data for the differences between the normal perfusion group and the DMSO-underperfusion with NE subgroup, and between the LV subendocardium and subepicardium were assessed statistically by the Student t-test. The one-way ANOVA and the Scheffe method were restricted to the underperfusion with NE subgroups.
Results
Characterization of diabetic state
The characteristics of the diabetic rats used in the isolated heart experiments were significantly different from w x those of the non-diabetic rats as reported previously 15 . Body and heart weights were significantly reduced together with a significant increase in plasma glucose: body Ž weight, 246 " 6 g y4"6 Dg, difference from those at . the streptozotocin treatment ; heart weight, 0.90 " 0.02 g; Ž . plasma glucose, 535 " 14 mgrdl n s 42 .
CPP during underperfusion with NE
In the DMSO subgroup, with the start of underperfusion, CPP decreased to about one third of the normal Ž . perfusion level Fig. 2 . NE infusion during underperfusion induced a transient moderate increase in CPP; CPP returned to almost the level during underperfusion without NE, and about 25 min after the onset of underperfusion with NE, CPP began to increase gradually. In the glyburide subgroup, about 17 min after the onset of underperfusion CPP began to increase markedly. In the presence of levcromakalim with glyburide, CPP during normal perfusion decreased significantly, and the changes in CPP during underperfusion with NE were similar to those in the DMSO subgroups. g from the normal perfusion levels were plotted as resting LVP and resting CF, respectively. 
Contractile dysfunction during underperfusion with NE
There were almost no significant differences among the three subgroups of underperfusion with NE in these parameters. Fig. 4 shows the changes in the developed CF and the peak qdFrdt and ydFrdt. The parameters during 13-20 min of underperfusion with NE were lower in the glyburide subgroup than in the other two subgroups.
Diastolic state during underperfusion with NE
Fig . 5 shows the changes in resting LVP and resting CF. In the normal perfusion group, neither values rose during the perfusion period. In the DMSO subgroup, the resting CF and the resting LVP began to increase about 15 and 20 min, respectively, after the onset of underperfusion with NE. In the glyburide subgroup, the resting CF and the resting LVP began to increase about 8 and 15 min, respectively, after the onset of underperfusion with NE, the increase being greater than in the DMSO subgroup. In the presence of levcromakalim with glyburide, the changes in both parameters during underperfusion with NE were similar to those in the DMSO subgroup. Fig. 6 shows the changes in resting LVP and resting CF in the glyburideq insulin subgroup. In the presence of insulin with glyburide, the changes in both values during underperfusion with NE were similar to those in the glyburide subgroup until 17 min after the onset of underperfusion with NE, and to those in the DMSO subgroup thereafter. Table 1 shows the changes in the tissue flow rate. During normal perfusion, the flow rate in the DMSO subgroup was greater in the LV subendocardium than in the LV subepicardium. However, at 60 min of underperfusion with NE, the decrease in flow was more marked in the subendocardium; the flow rate was smaller in the subendo- cardium than the subepicardium. In the glyburide subgroup, the changes in the flow rate were similar to those in the DMSO subgroup. Table 2 shows the changes in the regional myocardial energy metabolism in the LV free wall. During normal perfusion, the level of phosphorylation potential, the energy charge and tissue content of high-energy phosphate compounds were similar in the subendocardium and the subepicardium; the tissue lactate concentration and CPrP i ratio were slightly higher, and the levels of P and water i were slightly lower in the subendocardium. After a 60-min underperfusion with NE, all the metabolic parameters except ADP and subendocardial water significantly changed Ž . in both layers in the DMSO subgroup P -0.01 ; the metabolic changes were more marked in the subendocardium.
Regional myocardial flow distribution
Regional myocardial energy metabolism during underperfusion with NE
After a 60-min underperfusion with NE, the decreases in ATP and energy charge, the increase in AMP in both the subendo-and subepicardium, and the decrease in CP in the subendocardium were more marked in the glyburide subgroup than in the DMSO subgroup. In the presence of levcromakalim with glyburide, the changes during underperfusion with NE were similar to those in the DMSO subgroup. In the presence of insulin with glyburide, the changes in ATP and CP during underperfusion with NE were also similar to those in the DMSO subgroup. The tissue content of ADP did not change and the total adenine nucleotides decreased similarly in both layers of both DMSO and glyburide subgroups; the tissue levels of both substrates increased slightly in the presence of levcromakalim with glyburide.
After a 60-min underperfusion with NE, the increases in lactate and P in both layers were more marked in the i glyburide subgroup than in the DMSO subgroup. In the presence of levcromakalim or insulin with glyburide, the changes resembled those in the DMSO subgroup, but the lactate concentration in the subendocardium in the glyburide q levcromakalim subgroup was still greater than that in the DMSO subgroup.
After a 60-min underperfusion with NE, the glycogen levels were markedly low and the content in the subendocardium and the subepicardium was similar in the three subgroups.
After a 60-min underperfusion with NE, the phosphorylation potential and CPrP ratio, which reflects the state of i myocardial oxidative metabolism, were markedly decreased, particularly in the subendocardium. The changes were more marked in the glyburide subgroup. In the presence of levcromakalim or insulin with glyburide, the changes were similar to those in the DMSO subgroup.
After a 60-min underperfusion with NE, the water content did not change in the subendocardium and de- Table 1 Regional flow distribution in isolated perfused diabetic rat hearts Ž Tissue flow distribution was determined by the dye microspheres method, just before Normo: normal perfusion, 6.21"0.26 mlrminrg heart weight, . Ž .
Ž . Ž . ns11 and 60 min after the start of underperfusion 2 mlrminrg heart weight with 10 M norepinephrine NE Under in the 0.002% DMSO and the 10 y6 M glyburide subgroups. The hearts were dissected into 6 portions. Right ventricle s the right ventricular free wall; Septum s the ventricular Ž . septum; LV subendocardium s an inner half of the left ventricular free wall; LV subepicardium LVepi s an outer half of the LV free wall. Values are means"s.e. ) P -0.05, ) ) P -0.01 vs. respective Normo;
q P -0.05,P -0.01 LV subendocardium vs. subepicardium. There was no significant difference between the DMSO and the glyburide subgroups in the three parameters during normal perfusion and underperfusion. The hearts were quickly frozen in liquid nitrogen at 60-min normal perfusion, and at 60-min underperfusion 2 mlrminrg heart weight with 10 M y6 y4 Ž norepinephrine in the 0.002% DMSO, the 10 M glyburide, the glyburideq10 M levcromakalim and the glyburideq insulin 2 mUrminrg heart . weight subgroups. The left ventricular free walls of the frozen hearts were dissected into inner and outer halves, which corresponded, respectively, to the Ž . Ž . subendocardial subendocardium, endo and subepicardial portions subepicardium, epi . Further explanations provided in legend to Fig. 1 . ATP-FL: ATP was determined by the firefly luminescence method. AMP, ADP and ATP-HPLC were determined by high-performance liquid Ž . chromatography ns 5 only in HPLC data in normal perfusion group , and total nucleotides, energy charge and phosphorylation potential were calculated from the data and P content. The tissue lactate concentration, as a rough approximation, was estimated from the water and lactate content. The water i content was estimated from the wet weight of the solidly frozen tissue and the dry weight of the solid matter after a 5-h lyophilization. Values are means"s.e. Significant changes in all substrates except ADP and subendocardial water were observed between the normal perfusion group and the DMSO subgroup.
a P -0.05, b P -0.01 vs. DMSO subgroup and c P -0.05, d P -0.01 vs. glyburide subgroup, among the underperfusion with norepinephrine subgroups.
x P -0.05, y P -0.01 vs. epi.
creased in the subepicardium similarly in the three subgroups, and there was no significant difference between the layers.
Discussion
Glyburide, a sulphonylurea derivative, is used for treatment of non-insulin-dependent DM, because it augments the release of insulin from the beta-cells of the pancreas w x 20 . The beneficial effect is probably caused by blocking w x the K channels in the beta-cells 7 . However, concomi-ATP tant blockade of the K channels in the diabetic my-ATP ocardium may be harmful to the diabetic heart, particularly during ischemia, if opening of the K channels has a ATP protective effect on the diabetic ischemic heart as on the w x non-diabetic ischemic heart 9 .
The present study provides evidence that glyburide enhances diabetic myocardial damage during underperfusion with NE. Glyburide during underperfusion with NE accelerated the start of increase in LV diastolic stiffness and the abnormal myocardial energy metabolism in both LV layers of the isolated diabetic rat heart. The glyburideinduced deleterious effects were prevented by levcromakalim and partly by insulin.
Increased LV stiffness in isolated underperfused diabetic rat hearts
When hearts isolated from diabetic rats were perfused with a NE-containing fluid at a low flow rate, an increase in LV stiffness was accompanied by a decrease in the amount of water contained in the myocardial tissue. This indicates that the observed increase in the LV diastolic stiffness is attributable to myocardial contracture rather than to increased LV lumen volume, myocardial edema or w x the erectile effect, as we proposed previously 12,15 .
Regional myocardial flow distribution in isolated underperfused diabetic rat heart
The present findings indicate that the regional myocardial flow distribution during normal perfusion is greater in Ž . the LV inner layer subendocardium than in the outer Ž . layer subepicardium of the isolated diabetic rat heart.
When the distribution of low flow rates was examined 60 min after the start of underperfusion with a NE-containing fluid, the flow rate in the inner layer of the LV free wall was significantly lower than that in its outer layer. This reflects the abnormal regional myocardial energy metabolism very well. Regional blood flow rates as determined using multi-colored microspheres are reported to be well consistent with those measured using radioactive miw x crospheres 24 . The distribution of flow rates during perfusion of the isolated heart, determined in this experiment using dye microspheres, does not contradict that deterw x mined in situ in non-diabetic animals 25 .
In the isolated diabetic rat heart, underperfusion with NE caused a more marked flow decrease in the subendocardium than in the subepicardium in both the presence and absence of glyburide. Glyburide reportedly reduced the coronary blood flow of the non-diabetic heart; however, the coronary vasculature retains the capacity to dilate in response to oxygen demand produced by exercise when w x K channels are blocked 26 . In the present study, the ATP flow rate through the inner layers of the LV myocardium, measured 60 min after the start of underperfusion with NE, was similarly low in the glyburide-treated and untreated DMSO subgroup. The lack of a significant difference is probably because the left ventricular stiffness is markedly elevated even in the absence of glyburide after 60 min of underperfusion with NE.
Regional myocardial energy metabolism in isolated
underperfused diabetic rat heart w x As we have described in detail previously 12,13,15 , underperfusion of hearts isolated from diabetic rats, using a NE-containing fluid as a perfusate, resulted in a marked increase of LV stiffness and in abnormal myocardial energy metabolism. Changes such as an increase in myocardial AMP, P and lactate levels, suppression of oxidative i energy production and a significant decrease in high-energy phosphates and total adenine nucleotides were more marked in the LV inner layer than the outer layer.
In the present study, abnormalities of regional myocardial energy metabolism reflect the distribution of regional flow rates very well. An increase in LV stiffness and abnormalities of myocardial energy metabolism probably adversely affect the heart and thus precipitate heart failure.
InÕolÕement of the K channels in myocardial AT P dysfunction during underperfusion with NE of diabetic rat heart; the glyburide-induced deleterious effects
In the present study, glyburide treatment resulted in exacerbation of abnormal regional myocardial energy metabolism and an enhanced increase of LV stiffness during underperfusion with NE in the diabetic heart. That is, the increase in LV stiffness during underperfusion with NE appeared earlier and was greater in the glyburide-treated subgroup. Abnormal myocardial energy metabolism in both LV inner and outer layers was exacerbated significantly by treatment with glyburide.
It is suggested that in the non-diabetic heart, myocardial ischemia opens the K channels in the vascular smooth ATP muscle and myocardial cells, due to a decrease in the w x cytosolic ATP concentration 1,16,27 , an increase in the w x extracellular adenosine level 28 and the release of an acetylcholine-mediated, endothelium-derived hyperpolarizw x ing factor 29 , which leads to protection of the ischemic w x derangement of myocardium 9 . The activation of K ATP channels is thought to lead to an increase in regional coronary flow due to vasodilation, to a decrease in myw x ocardial contraction 19,27 and to preservation of high-enw x ergy phosphates 30 . The preconditioning effect of myocardial ischemia is also thought to be attributable to a similar mechanism, because the beneficial effects of preconditioning disappear if the K channels are blocked via the opening of voltage-dependent Ca 2q channels w x on the myocardial cell membrane 9 . The exacerbation of abnormal myocardial energy metabolism in the diabetic heart in the presence of glyburide, observed in the present study, may represent the total of the above-mentioned effects plus the adverse effect of myocardial cell calcium accumulation induced by the blockade of the K chan-ATP Ž nels i.e., an increase in the myocardial tension at diastole . and suppressed oxidative energy production .
In the present ex vivo study, the glyburide level which caused marked exacerbation of myocardial dysfunction during underperfusion with NE was 10 y6 M, which causes specific blockade of K channels and is similar to the ATP w x plasma glyburide levels seen in clinical cases 20 . Previw x ously 33 , we found that the glyburide level causing marked exacerbation of the underperfusion with NE injury Ž y7 . was lower in the non-diabetic heart 10 M than in the diabetic heart. In addition, the marked deleterious effects of glyburide at these levels were observed in the presence of 10 y6 M NE in both non-diabetic and diabetic hearts. These findings imply that the deleterious effect of glyburide on the underperfused diabetic heart varies with the severity of underlying diabetes mellitus and the activity of the sympathetic nervous system.
On the other hand, some investigators have reported that the glyburide-induced blockade of K channels led ATP Ž to a favorable outcome in the non-diabetic heart i.e., a decrease in the frequency of ischemia-induced ventricular
. w x fibrillation 34 . In the present study, this effect of glyburide could not be assessed because the heart was paced electrically throughout the experiments. Other limitations of the study are that the possible influences of blood components and reflex reaction in in-situ experiments are excluded because in ex vivo experiments the heart is innervated insufficiently and is perfused with KrebsHenseleit solution containing 11 mM glucose instead of blood.
PreÕentiÕe effects of leÕcromakalim on the glyburideinduced deleterious effects
Levcromakalim, a selective K q channel opener and a K channel opener, suppressed the glyburide-induced ATP exacerbation of myocardial dysfunction during underperfusion with NE in the isolated diabetic rat heart, the severity of myocardial dysfunction being reduced to a level comparable to that seen in the glyburide-untreated heart. Levcrow x makalim opens the K channels of blood vessels 18 ATP w x and myocardium 17,19 in non-diabetic animals. This action of levcromakalim is probably involved in the suppression of glyburide-induced exacerbation of myocardial dysfunction during underperfusion with NE in the diabetic heart. This supports the view that the earlier appearance of myocardial dysfunction during underperfusion with NE in the presence of glyburide treatment is due to its action of inhibiting the opening of the K channels. The present ATP study also indicates that levcromakalim preserves the adenine nucleotide level in ischemic myocardium of the diabetic heart. These findings suggest that in the diabetic heart the K channels open soon after the onset of ischemia and ATP thus protect the myocardium. Glyburide seems to inhibit this response of the K channels and thus enhances the ATP onset and severity of ischemia-caused myocardial injury.
Levcromakalim may suppress such actions of glyburide.
PreÕentiÕe effects of insulin on the glyburide-induced deleterious effects
w x In our previous study 12,14 , in vivo and ex vivo insulin reduced the injury associated with underperfusion with a NE-containing fluid in the isolated diabetic heart. In the present study, the glyburide-induced earlier exacerbation of myocardial dysfunction during underperfusion with NE was not reduced by ex vivo insulin. However, 20 min after the start of underperfusion, the elevation of LV stiffness and the abnormal myocardial energy metabolism in the heart treated with ex vivo insulin were reduced to the levels observed in the glyburide-untreated DMSO subgroup. These findings indicate that in the diabetic heart, insulin cannot inhibit the earlier and more severe exacerbation of myocardial dysfunction during underperfusion with NE caused by the K channel blocking action of gly-ATP buride. Once myocardial glycogen has been consumed almost completely during long-term underperfusion with a w x NE-containing fluid 15 , insulin may protect the myocardium, although incompletely, probably through promow x tion of glucose utilization 35 .
The effects of levcromakalim and insulin strongly suggest that in the diabetic heart the K channels open soon ATP after the onset of ischemia and thus protect the myocardium, and that the glyburide-induced earlier exacerbation of myocardial dysfunction during underperfusion with NE is due to its effect in suppressing the opening of the K channels. Furthermore, these findings partly explain ATP why treatment with sulphonylurea leads to detrimental w x effects in some diabetics 6 .
